Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1979 2
1980 1
1981 4
1982 6
1983 9
1984 11
1985 8
1986 5
1987 4
1988 12
1989 12
1990 50
1991 69
1992 81
1993 110
1994 158
1995 175
1996 223
1997 210
1998 229
1999 276
2000 303
2001 326
2002 346
2003 384
2004 340
2005 419
2006 396
2007 403
2008 438
2009 465
2010 483
2011 492
2012 554
2013 619
2014 658
2015 655
2016 706
2017 657
2018 594
2019 553
2020 182
Text availability
Article attribute
Article type
Publication date

Search Results

10,702 results
Results by year
Filters applied: . Clear all
Page 1
Natural history of hepatitis C.
Westbrook RH, Dusheiko G. Westbrook RH, et al. J Hepatol. 2014 Nov;61(1 Suppl):S58-68. doi: 10.1016/j.jhep.2014.07.012. Epub 2014 Nov 3. J Hepatol. 2014. PMID: 25443346 Free article. Review.
There has long been evidence that hepatitis C can lead to persistent infection in a high proportion of infected individuals, and can progress to chronic liver disease, cirrhosis and hepatocellular carcinoma (HCC). The transition from acute to chronic hepatitis …
There has long been evidence that hepatitis C can lead to persistent infection in a high proportion of infected individuals, a …
A global view of hepatocellular carcinoma: trends, risk, prevention and management.
Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. Yang JD, et al. Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604. doi: 10.1038/s41575-019-0186-y. Epub 2019 Aug 22. Nat Rev Gastroenterol Hepatol. 2019. PMID: 31439937 Free PMC article. Review.
Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death worldwide. Risk factors for HCC include chronic hepatitis B and hepatitis C, alcohol addiction, metabolic liver disease (particularly nonalcoholic fatty liver …
Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death worldwide. Risk factors for HCC include …
Hepatitis C virus infection and the risk of cancer among elderly US adults: A registry-based case-control study.
Mahale P, Torres HA, Kramer JR, Hwang LY, Li R, Brown EL, Engels EA. Mahale P, et al. Cancer. 2017 Apr 1;123(7):1202-1211. doi: 10.1002/cncr.30559. Epub 2017 Jan 24. Cancer. 2017. PMID: 28117886 Free PMC article.
BACKGROUND: Hepatitis C virus (HCV) infection causes hepatocellular carcinoma (HCC) and subtypes of non-Hodgkin lymphoma (NHL). ...These results support a possible etiologic role for HCV in an expanded group of cancers. Cancer 2017;123:1202-1211 …
BACKGROUND: Hepatitis C virus (HCV) infection causes hepatocellular carcinoma (HCC) and subtypes of non-Hodgkin lymphom …
The Epidemiology of Hepatocellular Carcinoma in the USA.
Kim HS, El-Serag HB. Kim HS, et al. Curr Gastroenterol Rep. 2019 Apr 11;21(4):17. doi: 10.1007/s11894-019-0681-x. Curr Gastroenterol Rep. 2019. PMID: 30976932 Review.
The recent epidemiological changes in major risk factors for HCC include increasing hepatitis C virus post-sustained virologic response, suppressed hepatitis B virus on nucleoside analogues, and alcoholic and non-alcoholic fatty liver disease. Non-alcoholic f …
The recent epidemiological changes in major risk factors for HCC include increasing hepatitis C virus post-sustained virologic …
The impact of treatment of hepatitis C with DAAs on the occurrence of HCC.
Roche B, Coilly A, Duclos-Vallee JC, Samuel D. Roche B, et al. Liver Int. 2018 Feb;38 Suppl 1:139-145. doi: 10.1111/liv.13659. Liver Int. 2018. PMID: 29427487 Review.
Hepatitis C virus infection is a major cause of chronic hepatitis resulting in cirrhosis and hepatocellular carcinoma (HCC). ...
Hepatitis C virus infection is a major cause of chronic hepatitis resulting in cirrhosis and hepatocellular carc …
Racial Disparity in Gastrointestinal Cancer Risk.
Ashktorab H, Kupfer SS, Brim H, Carethers JM. Ashktorab H, et al. Gastroenterology. 2017 Oct;153(4):910-923. doi: 10.1053/j.gastro.2017.08.018. Epub 2017 Aug 12. Gastroenterology. 2017. PMID: 28807841 Free PMC article. Review.
Cancer from the gastrointestinal tract and its associated excretory organs will occur in more than 300,000 Americans in 2017, with colorectal cancer responsible for >40% of that burden; there will be more than 150,000 deaths from this group of cancers in t …
Cancer from the gastrointestinal tract and its associated excretory organs will occur in more than 300,000 Americans in 2017, with co …
From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
Dimitroulis D, Damaskos C, Valsami S, Davakis S, Garmpis N, Spartalis E, Athanasiou A, Moris D, Sakellariou S, Kykalos S, Tsourouflis G, Garmpi A, Delladetsima I, Kontzoglou K, Kouraklis G. Dimitroulis D, et al. World J Gastroenterol. 2017 Aug 7;23(29):5282-5294. doi: 10.3748/wjg.v23.i29.5282. World J Gastroenterol. 2017. PMID: 28839428 Free PMC article. Review.
Hepatocellular carcinoma (HCC) is the most frequent primary liver malignancy and the third cause of cancer-related death in the Western Countries. The well-established causes of HCC are chronic liver infections such as hepatitis B virus or chronic h …
Hepatocellular carcinoma (HCC) is the most frequent primary liver malignancy and the third cause of cancer-related death in th …
Hepatitis C virus reactivation in cancer patients in the era of targeted therapies.
Yazici O, Sendur MA, Aksoy S. Yazici O, et al. World J Gastroenterol. 2014 Jun 14;20(22):6716-24. doi: 10.3748/wjg.v20.i22.6716. World J Gastroenterol. 2014. PMID: 24944464 Free PMC article. Review.
The purpose of this review is to summarize the evidence of hepatitis C reactivation in cancer patients in the era of targeted therapies. ...Post-transplant studies reported that mTOR was safely administered to patients with active hepatitis C wi …
The purpose of this review is to summarize the evidence of hepatitis C reactivation in cancer patients in the era of ta …
Pathogenesis, diagnosis, and management of cholangiocarcinoma.
Rizvi S, Gores GJ. Rizvi S, et al. Gastroenterology. 2013 Dec;145(6):1215-29. doi: 10.1053/j.gastro.2013.10.013. Epub 2013 Oct 15. Gastroenterology. 2013. PMID: 24140396 Free PMC article. Review.
These subtypes differ not only in their anatomic location, but in epidemiology, origin, etiology, pathogenesis, and treatment. ...Furthermore, CCAs are surrounded by a dense stroma that contains many cancer-associated fibroblasts, which promotes their progression. . …
These subtypes differ not only in their anatomic location, but in epidemiology, origin, etiology, pathogenesis, and treatment. ...Fur …
The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer.
Shiani A, Narayanan S, Pena L, Friedman M. Shiani A, et al. Cancer Control. 2017 Jul-Sep;24(3):1073274817729240. doi: 10.1177/1073274817729240. Cancer Control. 2017. PMID: 28975833 Free PMC article. Review.
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. Underlying chronic liver disease has been associated with an increased risk of developing HCC. ...Hepatitis C virus, hepatitis B virus (HBV), nonalcoho …
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. Underlying chronic liver disease …
10,702 results
Jump to page
Feedback